Post-authorisation Safety Study (PASS) of Influenza Vaccine in United Kingdom (UK)
Clinical trial NCT02567721 · COMPLETED
Trial details
- NCT number
- NCT02567721
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2015-10-01
- Primary completion
- 2015-11-01
- Enrollment
- 11530
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.